Gil Roth11.04.13
Phase II
Allegro begins vitreomacular traction trial . . . read more
Biothera NSCLC treatment hits primary endpoint . . . read more
Phase III
ADMA Bio completes enrollment for PIDD trial . . . read more
Merck HPV vax improves on Gardasil . . . read more
Filings
USB submits Vimpat sNDA . . . read more
Launches
Sagent launches Carboplatin Injection . . . read more
Silvergate launches Epaned for hypertension . . . read more
Allegro begins vitreomacular traction trial . . . read more
Biothera NSCLC treatment hits primary endpoint . . . read more
Phase III
ADMA Bio completes enrollment for PIDD trial . . . read more
Merck HPV vax improves on Gardasil . . . read more
Filings
USB submits Vimpat sNDA . . . read more
Launches
Sagent launches Carboplatin Injection . . . read more
Silvergate launches Epaned for hypertension . . . read more